FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3162937 · Received June 11, 2013

Report

Report Number
1030489-2013-02159
Event Type
Injury
Date Received
June 11, 2013
Report Date
November 28, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4): NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED BY A NON-MEDICAL PROFESSIONAL THAT ON THE PATIENT UNDERWENT A PROCEDURE FOR ANTERIOR CERVICAL FUSION AT C4-C5 USING RHBMP-2. SUBSEQUENTLY, THE PATIENT WAS ALLEGEDLY DIAGNOSED WITH ECTOPIC BONE GROWTH, AN INFLAMMATORY REACTION TO RHBMP-2/ACS, CHRONIC PAIN, AND ADDITIONAL SURGERIES.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2008 THE PATIENT UNDERWENT ANTERIOR CERVICAL DECOMPRESSION AND FUSION, WITH INSTRUMENTATION AND PLACEMENT OF INTERBODY PEEK GRAFT, C4-5. PREOPERATIVE DIAGNOSIS: C4-5 HERNIATED NUCLEUS PULPOSUS. PER-OP NOTES: ¿UNTIL A NERVE HOOK COULD BE EASILY PASSED ALONG THE COURSE OF EACH NERVE ROOT. THE INTERSPACE WAS SIZED TO A 6-MM GRAFT, AND A 6-MM POLYETHER-ETHER-KETONE GRAFT WAS FILLED WITH BONE MORPHOGENETIC PROTEIN SPONGES AND PLACED IN THE DISK INTERSPACE. A ANTERIOR CERVICAL PLATE WAS AFFIXED TO THE ANTERIOR CERVICAL SPINE WITH 13-MM FIXED ANGLE SCREWS IN ACCORDANCE WITH THE TECHNIQUE MANUAL.¿

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
262711 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 33 YR Required Intervention